Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Jelena Martinovic

Two-Thirds Of Physicians Say Psilocybin Therapy Can Help Treatment-Resistant Depression, New Survey Shows

Psilocybin-focused mental health care company COMPASS Pathways plc (NASDAQ:CMPS) and Sermo announced on Wednesday findings from a survey of Sermo physician members that showed two-thirds of doctors surveyed believe psilocybin therapy has potential therapeutic benefit for patients with treatment-resistant depression (TRD).

“Severe mental illnesses, such as treatment-resistant depression, have affected too many people in society for too long,” said Murali Doraiswamy MBBS, FRCP, professor of Psychiatry and Behavioural Sciences at Duke University's medical school.  

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.